We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
A thought leadership media platform working with trusted experts to bring innovative advancements to organisations through journalism. The Future Shapers aims to re-imagine how information is delivered globally and the ways it can help small to large communities innovate further, avoiding the use of advertisers and paywalls.
days to go: Expired investment: £41,610
Clim8 is a financial technology company that aims to move billions of pounds of investment into sectors such as clean energy, clean technology, sustainable food, smart mobility, and recycling. It is authorised by the Financial Conduct Authority (FCA). The company quotes United Nations data arguing that the World needs to invest $2.4 trillion every year into clean energy, from now until 2035, to meet climate change targets. Clim8 aims to capitalise on this objective. It launched its app on iOS and Android in private beta in October 2020 and then in the App Store in March 2021. It claims that its users have invested from £25 up to £97,000. The company has raised £5 million in venture capital to date, secured up to £2 million in airtime for equity from Channel 4 Ventures, and garnered a 4.8 star rating in the App Store, from a cumulative 100 reviews. The company will use the investment to accelerate user acquisition and launch new product offerings including pensions.
days to go: Expired investment: £2,849,790
Tribe are a modern, natural nutrition brand, based online and tailored to the customer. The UK sport nutrition market is growing at 23% a year and Tribe have already gained 25,000 members purchasing products from them. All products are formulated for performance and made from the highest natural ingredients. 
days to go: Expired investment: £1,747,470
@pizza is a pizza maker that aims to disrupt the £5.2 billion UK pizza and Italian restaurant market. The company asserts that its modern and fast counter operation can create hand-crafted pizzas in 90 seconds. @pizza is currently ranked the #1 restaurant in Birmingham and #1 pizza restaurant in Edinburgh for over two years with its existing fast-casual restaurants. The company plans to use ‘semi-permanent’ restaurant units situated in high traffic density suburban car parks to drive growth. @pizza believes that these restaurants can cook ten high-quality pizzas a minute, offer contactless takeaway and home delivery in the wake of COVID-19, and incorporate the UK’s first pizza drive-thru business model. The company will use the investment to broaden its customer base, giving consumers the bespoke pizza they want, as well as, how, where and when they want it without significant fixed property costs. It also aims to create franchise opportunities across UK cities.
days to go: Expired investment: £1,257,210
Tart London is a bakery and coffee shop with one location overlooking Clapham Common. They also have their heart set on a second location which they will aim to move into by summer. The use of the proceeds will go towards the rent for the new location as well as getting the premises ready for opening. 
days to go: Expired investment: £229,294
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph